BIOPHARMA: Biopharmaceutical Products in the U.S. and European Markets, 12th edition

BIOPHARMA: Biopharmaceutical Products in the U.S. and European Markets, 12th edition

BIOPHARMA^®: Biopharmaceutical Products in the U.S. and European Markets

The only information resource/reference (Web database) specializing in biopharmaceutical products!

Encyclopedic monographs concentrate on products' biotechnology and commercial aspects (the hard-to-find information)
Includes all biopharmaceuticals - recombinant and other proteins, monoclonal antibodies, vaccines, enzymes, blood products, radioimmune conjugates, cultured cells/tissues; all US/EU-approved reference, biosimilar, biobetter and biogeneric products
Besides detailed descriptions and indexing, includes much unique competitive, technological, marketing and regulatory intelligence available nowhere else (making BIOPHARMA invaluable)
Full-text Web database subscriptions available for individuals (by password) and organizations (by I.P. nos.)

New! Database Upgrade: BIOPHARMA has become "The Reference Products Reference" with the addition of a Biosimilars/Biobetters Search Module (with projected US and EU patent and market and data exclusivities expiration and product launchability dates)
New! "FDA Biopharmaceutical Product Approvals and Trends in 2012," BioProcess International, vol. 11, no. 3, March 2013, pp. 18-27.

Quick tour: Description Reviews Product database Company database Order

The Bottom line -- If you have an interest in biopharmaceuticals, whether innovative or biosimilars/biobetters/biogenerics, the BIOPHARMA Web database is an essential must-have information resource! BIOPHARMA is the first place to look for biopharmaceutical-related information, serving as the basic common denominator (what your competitors have access to, but you don't) information resource/reference for this industry. The database provides much high value, even invaluable, information, including much retrievable nowhere else; has excellent reviews; and is a bargain by pharmaceutical information standards and compared to alternatives (either doing without or spending much more time and/or money just to retrieve bits and pieces of information about these products and companies). BIOPHARMA provides you with the fruits of well over 3.5 man-years of effort by world-class a biotech/pharmaceutical information specialist.

Authored by a single individual and now in its 12th year, BIOPHARMA provides a level of consistency in coverage, presentation, indexing, etc. not found in most other pharmaceutical/biotech information resources. But with the database being a massive work, >1.3 million words, likely >2,600 dense pages if printed, with over 670 product monographs, authorship by an individual also has its limitations. For example, preexisting monographs are now generally updated with new information added rather than being fully rewritten/updated (so tenses can be off, e.g., "will" used vs. now proper use of "is" or "was").

Description/Flyer; Order form

Reviews - reviews from industry, scientific, professional association and library publications

Web Databases
Products:
Companies:
Password

Free Public Databases! View portions of monographs and indexing; extensive search capabilities
Web database subscriptions - Full access for individuals and organizations

Sample Full Product Monographs - full entries from the database - Need to see more? Request a trial database password.
- Glucocerebrosidase, rDNA/Protalix (Elelyso; recently approved, with more to be added, with monographs completed after first product approvals)
Indexes: These are static lists, useful to spot index terms used. It is always best to search the database, check relevant entries for their indexing, etc.
- Companies, Company Role, State/Country and Marketing Territory Indexes
From the last printed book version (6th edition, 2007; then 2 vol., 1603 dense pages; now much larger): Coverage; User's Guide
About the Author & Publisher and his company, the Biotechnology Information Institute
Related Web sites:
     BIOSIMILARS.com
     FDA Biopharmaceutical Approvals
     U.S. BIOPHARMACOPEIA Registry of Biopharmaceutical Products

Contact the Author/Publisher:

Ronald A. Rader

Biotechnology Information Institute
1700 Rockville Pike, Suite 400
Rockville, MD 20852

E-Mail: biotech@biopharma.com
Phone: 301-424-0255 (9AM-5PM, Eastern U.S.)

Copyright©2013. Part of the BIOPHARMA® suite of biopharmaceutical information products/services.
BIOPHARMA® is a registered U.S. trademark.